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Spheres of Influence
A Distinguished Career in the Service of Cancer
Prevention
After devoting more than 26 years to the
International Agency for Research on
Cancer, the last 12 years as director,
Lorenzo Tomatis retired in December
1993. Throughout these years Tomatis has
been the tireless embodiment of the
IARC's mission: to conduct and coordinate
research at an international level aimed at
cancer prevention through the application
of scientific knowledge of the causes of
cancer.
IARC, located in Lyon, France, is an
independently financed, intergovernmental
organization within the framework of the
World Health Organization. Research at
IARC, which Tomatis conducted, guided
and expanded during his tenure there, is
largely multidisciplinary, bringing together
the results of epidemiological and labora-
tory studies and linked by collaborative
research agreements with researchers in 56
countries on all 5 continents.
EarlyYears
Tomatis was born and had his early educa-
tion in Italy. He obtained his medical
degree from the University of Turin in
1953. After a briefstint as a medical officer
with a regiment of Alpine troops, he
returned to the university to specialize in
occupational diseases. It was here that his
interest in the role ofchemicals as potential
causes ofcancer began.
In the mid-1950s, Tomatis was begin-
ning to broaden his horizons and, like
other young Italian medical doctors at that
time, he saw exciting research opportuni-
ties in the United States. In 1959, Tomatis
traveled across the Atlantic to join Phillipe
Shubik's team at the Division ofOncology
in the Chicago Medical School. Shubik's
group had already established an interna-
tional reputation in the field of chemical
carcinogenesis, and Tomatis was rapidly
absorbed into the team. According to
Shubik, now director of the Toxicology
Forum in Oxford, even then Tomatis
showed great promise as a basic research
worker: "He was a careful and thoughtful
investigator who was able to think ofprob-
able advances before manyothers. He orga-
nized a tissue culture laboratory in my
department before this field had achieved
its present importance."
Tomatis's enthusiasm and willingness
to face achallenge carried over into his per-
sonal life as well. Shubik recalls an instance
early on in which Tomatis and his wife
were visiting with Shubik at his lake house
in Canada, having driven from Chicago in
an old Chevrolet. Says Shubik, "[The car]
had mechanical problems after arrival and
the local mechanic wondered ifit was ade-
quate to get them home. However, a while
later I heard that they had driven it to the
Yukon and were continuing to explore
North America."
Tomatis's first two publications from
Chicago-one on the induction of tumors
in the hamster with o-amino-azotoluene
and the other a study ofthe role ofcroton
oil in skin carcinogenesis-foretold the sci-
entific path that he has developed and
advanced ever since. Interestingly, his co-
authors with Shubik were both fellow
Italians-Giuseppe Della Porta, on the
first paper, former director ofthe Division
ofExperimental Oncology in the National
Cancer Institute in Milan, and on the sec-
ond paper, Benedetto Terracini, now chair
ofthe Department of Biomedical Sciences
and Human Oncology at the University of
Turn.
Tomatis continued to publish through-
out his stay in Chicago, but in 1965 his
research took an important new direction
with a paper in which he reported an
increased incidence of tumors in the first
(F1) and second (F2) generations of off-
spring from pregnant mice that had been
exposed to a polycyclic hydrocarbon,
dimethylbenzanthracene. He continued to
pioneer this new aspect of carcinogenesis
research and was awarded an Eleanor
Roosevelt International Cancer Fellowship
in 1965-1966 to study the response to
neonatal exposure to carcinogens. When
he joined IARC following that fellowship,
transplacental carcinogenesis was one of
the themes that Tomatis pursued with his
new colleagues.
Joining IARC
Tomatis joined IARC in November 1967
at the age of 38. He arrived to create and
establish the unit ofchemical carcinogene-
sis and spent his career there developing
the field in which he had already estab-
lished his reputation. Studies of perinatal,
transplacental, and multigenerational car-
cinogenesis remained a major interest for
Tomatis, and he was quick to see that the
emerging field ofmolecular biology would
contribute to a much more refined under-
standing ofthe mechanisms that might be
involved in the transmission of carcino-
genic risk from one generation to another.
Says Takashi Sugimura, director of the
National Cancer Center in Japan, who is
both a friend and colleague of Tomatis,
"His pioneering scientific contributions on
transplacental carcinogenesis are beginning
to focus the attention of more and more
scientists on this area ofcarcinogenesis."
Nikolai P. Napalkov, assistant director-
general ofthe World Health Organization,
calls Tomatis's multigenerational studies
some of his greatest contributions to the
field of carcinogenesis. Napalkov and
Tomatis met in the early 1960s when
Tomatis was at the Chicago Medical
School and Napalkov was also doing
research on chemical carcinogenesis at the
Sloan Kettering Institute at the University
ofCalifornia at Berkeley. The two became
friends and collaborators over the years,
working on joint projects in experimental
carcinogenesis. Regarding Tomatis's
research methods, Napalkov has the high-
est respect: "Dr. Tomatis has a systematic
knowledge of experimental pathology-
both human and animal-that is indis-
pensable to [his research] and ensures that
his data are always very solid. There is no
reason to hesitate about the validity ofhis
findings."
The overall objective ofIARC is to pre-
vent human cancer, and identifying envi-
ronmental carcinogens as the prerequisite
for their removal or, at least, reduction, is a
major step toward that goal. One of
Tomatis's major contributions to IARC
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the evidence of animal carcinogenicity in
long-term experiments as a valid criterion
for evaluating possible carcinogenic risks to
humans, alongside or, even more impor-
tantly, in the absence of, epidemiological
evidence. Tomatis worked to establish this
balanced perspective in which human epi-
demiology and experimental results are
both seen as essential to the identification
ofhuman risks.
Tomatis also forecast the advantage of
developing short-term in vitro mutagenici-
ty assays, which could serve as valuable
indicators of substances that needed fur-
ther study. In addition, Tomatis encour-
aged research on the role of host factors,
such as endogenous activation ofxenobiot-
ic chemicals, in carcinogenesis and into the
mechanisms ofaction ofcarcinogens, con-
centrating particularly on the interaction
between carcinogens and DNA-research
that IARC intends not only continue, but
to expand in the coming years.
A CrowningAchievement
In 1969, Tomatis initiated what has
become in the eyes ofmany IARC's singu-
lar most important contribution to cancer
prevention, its Programme on the
Evaluation of Carcinogenic Risks to
Humans and the publication of the pro-
gram's findings in a monograph series. The
program has won an international reputa-
tion for its scientific validity, impartiality,
and integrity and for its contribution to
preventive measures and public health.
Says Sugimura ofthe monograph series, "I
can say that many regulatory, academic,
and industrial communities draw practical-
ly their entire evaluation of chemical risk
from them."
The first working group ofinternation-
ally recognized experts, chaired by Shubik,
met in Lyon in December 1970 to prepare
the scientific criteria that would be used in
the monographs of the program and to
make preliminary evaluations of the data
on five substances. These 5 evaluations,
together with those of 14 more substances,
were considered by a working group that
met in December 1971, and made up the
first volume of the IARC Monograph
Series which was published in 1972, cover-
ing organic, inorganic, and natural prod-
ucts. The initial volume was well received
and the program was truly launched. Since
then, with the scientific collaboration and
financial support of the U.S. National
Cancer Institute, NIEHS, and the Com-
mission of the European Communities,
among others, the program has undergone
considerable expansion.
To date, 58 volumes of monographs
(often referred to as "orange books"
because of the color of their covers) have
been published, and another is currently in
press. Every effort has been made to ensure
the maximum dissemination of these eval-
uations both to national health authorities
and the scientific community. The mono-
graphs, which began with evaluations on
man-made and naturally occurring chemi-
cals, have greatly widened in scope in the
more than 20 years of their existence to
include evaluations ofmyriad exposure cir-
cumstances such as industrial processes and
occupations and lifestyle risk factors such
as diet, drugs, alcohol, and cigarette smok-
ing. It is perhaps for his continuous efforts
in publishing the monograph series that
Tomatis is most highly regarded. David P.
Rall, former director ofNIERS and a col-
league ofTomatis's for more than 20 years
says, "To keep the series running for 20
years and to maintain it at such a high level
is an unprecedented achievement."
According to Sugimura, the monographs
represent a continuing legacy from
Tomatis that can never be forgotten;
Sugimura calls the monographs "a box of
jewels of the knowledge of mankind on
chemical carcinogenesis."
Parallel to the development of the
monographs program, IARC has made an
effort to rationalize carcinogenicity testing
at the international level. Because animal
experiments are costly and take several
years to complete, it is important to know
who is testing what before setting up a
series of experiments in order to avoid
unnecessary duplication ofwork and build
on the research ofothers. To facilitate this
kind of communication, IARC has pub-
lished Information Bulletins periodically
since 1973, now called the Directory of
Agents Being Testedfor Carcinogenicity.
These directories provide companion and
cross-linked volumes to the annual
Directories ofOn-going Research in Cancer
Epidemiology, also published by IARC.
Global Vision
When Tomatis assumed the responsibili-
ties ofdirector ofIARC in 1982, not only
did he work to further apply and integrate
his well-established philosophy ofdevelop-
ing the interaction between experimental
research and epidemiology studies, but he
expanded his efforts to strengthen the role
of IARC, not just in identifying cancer
risks, but in research into different aspects
of cancer prevention and control. An out-
standing example is the Gambia Hepatitis
Intervention Study, where a plan for coun-
trywide hepatitis vaccination of all new-
born children has been set up, in conjunc-
tion with a cancer registration scheme, that
will produce important information on the
effectiveness of this measure in preventing
primary liver cancer.
Apart from the important and funda-
mental scientific aspects of the Gambia
study, it is not incidental that Tomatis
should give support to a study in a devel-
oping country; many of his writings have
demonstrated his consciousness of the
social aspects of the cancer problem
throughout the world. It is evident that
Tomatis views cancer not just as multiple
diseases, but more as a global public health
problem. In that context, he has drawn
attention to the relationship between
poverty and cancer risk, not only in devel-
oping countries but also in industrialized
countries where higher cancer risks and
lower socioeconomic class go hand in
hand. This perspective is spelled out in
detail in an editorial Tomatis wrote last
year on poverty and cancer published in
Cancer Epidemiology, Biomarkers and
Prevention. Other examples of this com-
mitment to extending IARC's research
activities abound and include study of the
risks of occupational exposures in newly
industrialized societies and assessment of
the effects that the spread of the AIDS
virus might have on the burden ofcancer.
In 1990, IARC published Cancer:
Causes, Occurrence and Control a synthesis
ofcurrent scientific knowledge and philos-
ophy relating to cancer causation and pre-
vention that attempts to quantify on a
global scale the benefits of the practical
application ofthis knowledge. Tomatis was
both inspirer and editor-in-chief of this
book, to which most ofthe IARC scientists
contributed. At the end of the introduc-
tion to this book, Tomatis sets out his
thoughts on cancer policy and priorities, of
which two points stand out as what he
believes are limiting factors in the success-
ful development of research in cancer pre-
vention. One, says Tomatis, is "the compe-
tition between military expenditures . . .
and funds allocated for education and
health." The other is the consideration of
basic and applied research as separate and
competing areas, which he calls "a grave
error, which can only serve the purpose of
preventing scientists from forming a com-
mon front in spending the available
resources rationally and efficiently and per-
haps obtaining more ofthem."
A Man ofManyTalents
Although Tomatis's more than 200 scien-
tific publications are available and accessi-
ble to all those who can read English, hid-
den from all except those who read Italian
are the literary works signed by Renzo
Tomatis.
His first book, II Laboratorio (The
Laboratory), was published in 1965 and is
based on his own daybook during one year
(1962-63) in Shubik's laboratory in
Chicago. The book, which reveals an
accomplished literary style, may be read as
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a presentation for the layman of the daily
work ofa young scientist, as well as a com-
parison of the Italian and the American
ways oflife. IILaboratorio earned populari-
ty in Italy, particularly among young
researchers, mainly for its lucid and open
critique of the scientific establishment of
their country, in particular of the archaic
structure of the university. As a testament
to his writing skills, Napalkov says that
Tomatis proved to be so clever in his
depictions of Italian academics and scien-
tists that "it was clear soon after the book's
publication that he would never be able to
pursue his career in Italy." What may have
been Italy's loss has certainly been the
world's gain.
The extent of Tomatis's influence on
the field of cancer prevention is account-
able, in large part, to what Sugimura calls
his "vast knowledge on chemical carcino-
genesis" and his "sincere and noble person-
ality as a scientific leader," which has
enabled him to guide and develop one of
the leading research agencies in the world.
On a more personal level, he is described
by his colleagues as having "sharp eyes and
a good sense of humor," "a knowledge of
all the wonderful restaurants in and around
Lyon," and a "good sense ofart history, as
well as a philosophical approach to many
life problems," all ofwhich no doubt have
served to enrich not only his own life, but
the lives of those with whom he has come
into contact.
Tomatis's other literary works, La
Ricerca Illimitata (The Unlimited Research,
1974), Visto dall'Interno (Seen from the
Inside, 1981), and Storia Naturale di un
Ricercatore (Natural History ofa Researcher,
1985), have all had considerable, if some-
what lesser, impact on the Italian scientific
community. In these books Tomatis
explores the theme of the social implica-
tions of science-and of medical research
in particular-as he continuously poses the
question ofwhat is the ultimate goal ofthe
work ofthe scientist, split between person-
al ambition and the general good. The
reader finds perhaps more questions than
answers in his books; the answers have to
be sought in the life ofLorenzo Tomatis-
a life which continues to be conducted
with scientific rigor and moral integrity.
Harri Vainio
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